+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vascular Grafts Market Size, Share & Trends Analysis Report by Product (Hemodialysis Access Grafts, Endovascular Stent Grafts), by Application, by Raw Material, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5450250
The global vascular grafts market size is anticipated to reach USD 3.1 billion by 2030 and is expected to expand at a CAGR of 7.0% during the forecast period. The rising number of dialysis procedures and prevalence of chronic kidney diseases, heart attacks, atherosclerotic heart diseases, and stroke is boosting the adoption of vascular grafts. Moreover, the rising demand for minimally invasive surgeries among the population is impelling the market growth.



Furthermore, the increasing medical applications and developments in intraoperative techniques are driving the market. Peripheral vascular disease affects more than 200 million people worldwide. This is anticipated to raise the demand for vascular grafts during the forecast period. The outbreak of COVID-19 had a negative impact on the market growth due to the deferrals in non-essential medical procedures. It also affected the sales and operation of companies.

In 2021, the endovascular stent-graft products segment dominated the market with a revenue share of 63.8% due to its increasing adoption in response to the rising cases of aortic aneurysms. According to the data published by CDC, in 2019, about 9,904 deaths were witnessed due to aortic aneurysms in the United States. An unhealthy lifestyle has raised the prevalence of cardiac diseases and renal disease, thereby impelling the market growth.

Additionally, the increasing geriatric population and rising disposable income coupled with healthcare expenditure in emerging countries is contributing to market growth in these regions. The peripheral vascular grafts segment is expected to grow at the fastest rate due to increasing use in peripheral artery bypass. Also, the rising cases of hardening of arteries is boosting the demand for peripheral vascular graft.

The cardiac aneurysm application segment held the majority share in 2021 owing to the rising cases of raised blood pressure, hyperglycemia, hypercholesterolemia, etc. Also, the rising geriatric population and increasing cases of atherosclerotic heart diseases among the population are impelling the market growth. Moreover, the shifting trend toward minimally invasive treatments has raised the adoption of minimally invasive vascular implants to treat cardiac aneurysms, thereby boosting the segment growth.

On the other hand, the vascular occlusion application segment is anticipated to witness the fastest growth rate due to the increasing prevalence of vascular occlusion disease and the availability of graft procedures. Moreover, the development of novel therapies to treat vascular occlusion is anticipated to drive the market during the forecast period.

As of 2021, the polytetrafluoroethylene raw material segment held the majority share in the market and is expected to witness the fastest growth rate during the forecast period. The growth is attributed to its capability of tolerating pressures and flows in large and medium arteries; moreover, it offers low degradation and infection risk.

The key players offering innovative products that offer maximum protection and help reduce the pain is impelling the market growth. For instance, Biovic offers AVATAR PTFE Vascular Graft. It is developed using Humidity Resistant Technology and has porous microstructure on both internal and external surfaces to maximize tissue in-growth and healing response.

North America dominated the market in 2021 owing to the rising geriatric population and associated health diseases. Moreover, the well-developed healthcare infrastructure and rising adoption of products with technological advancement are propelling the market growth. Also, the increasing investments in research and development activities in the region are contributing to the market growth. On the other hand, MEA is expected to witness the fastest growth during the projection period due to rising cases of people suffering from cardiovascular diseases in the region.

Vascular Grafts Market Report Highlights

  • The global market size is anticipated to reach USD 3.1 billion by 2030, owing to the increasing prevalence of cardiovascular disease and the shifting trend toward minimally invasive procedures.
  • The endovascular stent-grafts product segment dominated the market in 2021 owing to rising cases of aneurysms and increasing patient preference for endovascular stent-grafts.
  • The cardiac aneurysm application segment dominated the market in 2021 owing to the rising prevalence of cardiovascular diseases across the globe.
  • Polytetrafluoroethylene raw material segment dominated the market in 2021 majorly due to the rising demand for engineered prosthetics products.
  • North America dominated the market in 2021 majorly due to the development of novel products, increasing R&D activities, and developed healthcare infrastructure.
.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Vascular Grafts Market

What is the estimated value of the Global Vascular Grafts Market?

The Global Vascular Grafts Market was estimated to be valued at $1.8 Billion in 2022.

What is the growth rate of the Global Vascular Grafts Market?

The growth rate of the Global Vascular Grafts Market is 7.0%, with an estimated value of $3.1 Billion by 2030.

What is the forecasted size of the Global Vascular Grafts Market?

The Global Vascular Grafts Market is estimated to be worth $3.1 Billion by 2030.

Who are the key companies in the Global Vascular Grafts Market?

Key companies in the Global Vascular Grafts Market include Medtronic plc, Terumo Corporation, Lemaitre Vascular, Inc., C.R. Bard; W.L. Gore and Associates, Inc., Cook and Getinge Ab.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Research Scope and Assumptions
1.4.1 Methodology
1.4.1.1 Analysis Of The Company Market Share
1.4.1.2 Analysis Of Commodity Flow Model
1.5 Market Formulation & Validation
1.5.1 Global Market: CAGR Calculation
1.5.2 Global Segment Share Calculation
1.6 List to Data Sources
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3. Global vascular grafts market Variables, Trends & Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Global Vascular Grafts Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.3 Market Opportunity Analysis
3.3 Global Vascular Grafts Industry Analysis-Porter’s
3.3.1 Bargaining Power Of The Suppliers
3.3.2 Bargaining Power Of The Buyers
3.3.3 Threat Of Substitution
3.3.4 Threats From New Entrants
3.3.5 Competitive Rivalry
3.4 Global Vascular Grafts Industry Analysis-PEST
3.4.1 Political Landscape
3.4.2 Economic Landscape
3.4.3 Social Landscape
3.4.4 Technology Landscape
3.5 Major Deals & Strategic Alliances Analysis
3.6 Impact of COVID-19 Pandemic on global vascular grafts market
Chapter 4. Global vascular grafts market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
4.3 Vendor Landscape
4.3.1 List Of Key Distributors/Channel Partners
4.3.2 Key Customers)
4.3.3 Company Sales Value, 2016 To 2021 (USD Million)
4.3.4 Key Customers List Of Key Emerging Companies/Technology Disruptors/ Innovators
4.3.5 Company Market Position Analysis (Geographical Presence, Product Portfolio, Key Alliance, Industry Experience)
Chapter 5. Global vascular grafts market: Product Market Estimates & Trend Analysis
5.1 Global Vascular Grafts Market: Product Analysis
5.1.1 Hemodialysis Access Grafts
5.1.1.1 Global hemodialysis access grafts market value estimates and forecasts, 2016-2030 (USD Million)
5.1.2 Endovascular Stent Grafts
5.1.2.1 Global endovascular stent grafts market value estimates and forecasts, 2016-2030 (USD Million)
5.1.3 Coronary Artery by-Pass Grafts
5.1.3.1 Global coronary artery by-pass grafts market value estimates and forecasts, 2016-2030 (USD Million)
5.1.4 Vascular Grafts For Aorta Disease
5.1.4.1 Global vascular grafts for aorta disease market value estimates and forecasts, 2016-2030 (USD Million)
5.1.5 Peripheral Vascular Grafts
5.1.5.1 Global peripheral vascular grafts market value estimates and forecasts, 2016-2030 (USD Million)
Chapter 6. Global vascular grafts market: Application Estimates & Trend Analysis
6.1 Global Vascular Grafts Market: Application Movement Analysis
6.1.1 Cardiac Aneurysm
6.1.1.1 Global cardiac aneurysm market estimates and forecasts, 2016-2030 (USD Million)
6.1.1.2 Endovascular Stent Graft
6.1.1.2.1 Global endovascular stent graft market estimates and forecasts, 2016-2030 (USD Million)
6.1.1.3 Vascular Graft In Cardiac Aneurysm
6.1.1.3.1 Global vascular graft in cardiac aneurysm market estimates and forecasts, 2016-2030 (USD Million)
6.1.2 Kidney Failure
6.1.2.1 Global kidney failure market estimates and forecasts, 2016-2030 (USD Million)
6.1.3 Vascular Occlusion
6.1.3.1 Global vascular occlusion market estimates and forecasts, 2016-2030 (USD Million)
6.1.4 Coronary Artery Disease
6.1.4.1 Global coronary artery disease market estimates and forecasts, 2016-2030 (USD Million)
Chapter 7. Global vascular grafts market: Raw Material Estimates & Trend Analysis
7.1 Global Vascular Grafts Market: Raw Material Movement Analysis
7.1.1 Polyester Vascular Grafts
7.1.1.1 Global polyester vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
7.1.2 Polytetrafluoroethylene Vascular Grafts
7.1.2.1 Global polytetrafluoroethylene vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
7.1.3 Polyurethane Vascular Grafts
7.1.3.1 Global polyurethane vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
7.1.4 Biological Material Based Vascular Grafts
7.1.4.1 Global biological material based vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
7.1.4.2 Human Saphenous and Umbilical Veins
7.1.4.2.1 Global human saphenous and umbilical veins market estimates and forecasts, 2016-2030 (USD Million)
7.1.4.3 Tissue Engineered Materials
7.1.4.3.1 Global tissue engineered materials market estimates and forecasts, 2016-2030 (USD Million)
Chapter 8. Vascular Grafts Market: Regional Estimates & Trend Analysis
8.1 Regional market snapshot (USD Million)
8.2 Vascular grafts market: regional movement analysis, USD Million, 2020 & 2030, USD Million
8.3 North America
8.3.1 North America vascular grafts market estimates and forecasts, 2016 -2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
8.4 Europe
8.4.1 Europe vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.4.2 Germany
8.4.2.1 Germany vascular grafts market estimates and forecasts, 2016-2030 (USD Million ))
8.4.3 U.K.
8.4.3.1 U.K. vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.4.4 France
8.4.4.1 France vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.4.5 Italy
8.4.5.1 Italy vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.4.6 Spain
8.4.6.1 Spain vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5 Asia Pacific
8.5.1 Asia Pacific vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5.2 Japan
8.5.2.1 Japan vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5.3 China
8.5.3.1 China vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5.4 India
8.5.4.1 India vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5.5 Singapore
8.5.5.1 Singapore vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.5.6 South Korea
8.5.6.1 South Korea vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.6 Latin America
8.6.1 Latin America vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.6.2 Brazil
8.6.2.1 Brazil vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.6.3 Mexico
8.6.3.1 Mexico vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.6.4 Argentina
8.6.4.1 Argentina vascular grafts market estimates and forecasts, 2016-2030 (USD Million )
8.7 MEA
8.7.1 MEA vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
8.7.4 UAE
8.7.4.1 UAE vascular grafts market estimates and forecasts, 2016-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1 Company Profiles
9.1.1 Medtronic plc
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Terumo Corporation
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 LeMaitre Vascular, Inc.
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 C.R. Bard; W.L. Gore and Associates, Inc.
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Cook
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Product Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 Shanghai Suokang Medical Implants Co. Ltd.
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Getinge AB
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives

Companies Mentioned

  • Medtronic plc
  • Terumo Corporation
  • Lemaitre Vascular, Inc.
  • C.R. Bard; W.L. Gore and Associates, Inc.
  • Cook
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Getinge Ab

Methodology

Loading
LOADING...